Recently diagnosed with HIV? Click here

Understanding HIV treatments

Having a good level of treatments literacy is a key to living successfully with HIV. Issues such as different drug classesA group of anti-HIV drugs with the same target of action. Anti-HIV drug classes include nucleoside analogue reverse transcriptase inhibitors, protease inhibitors and non-nucleoside analogue reverse transcriptase inhibitors, as well as several others. Combining drugs from three or more classes is the basis of Highly Active Antiretroviral Therapy (HAART)., resistanceHIV which has mutated and is less susceptible to the effects of one or more anti-HIV drugs is said to be resistant., adherance and side effects are covered below.

Raltegravir approved for first line

Positive Living article • Adrian Ogier • 3 September 2010
Treating HIV

The Pharmaceutical Benefits Scheme[Pharmaceutical Benefits Scheme] The federal government program which subsidises medication costs in Australia. Anti-HIV drugs are part of a special part of the PBS called Section 100 (S100) which is used for expensive, highly specialised drugs. (PBS) has broadened access to raltegravir (Isentress) beyond treatment-experienced adults.

Raltegravir is now also available for people who are first starting HIV treatment.

Raltegravir + Truvada is now one of four preferred commencing regimens in the Australian HIV Treatment Guidelines. read more »

Commitment to people living with HIV and best health outcomes: Gilead

Media release • 9 August 2010

Last week NAPWHA raised concerns related to a recent advertising campaign initiated by Gilead Australia, running in print and radio media. Through discussion Gilead have agreed to consult more widely on future patient based initiatives, and end the current advertising campaign earlier than planned. read more »

‘Live a Little Simpler’ ads a little too simplistic

Media release • 5 August 2010

A pharmaceutical company advertising campaign will create confusion about HIV treatment choices and risks complicating the doctor-patient relationship, the National Association of People Living with HIV/AIDS (NAPWHA) has said. read more »

The START Trial: information for prospective participants

Resource • 21 May 2010

Information about the START trial, which is seeking to establish the best time to start HIV treatment. read more »

RESISTING RESISTANCE

Positive Living article • Neil McKellar-Stewart • 4 March 2010

Developing resistanceHIV which has mutated and is less susceptible to the effects of one or more anti-HIV drugs is said to be resistantHIV which has mutated and is less susceptible to the effects of one or more anti-HIV drugs is said to be resistant.. to HIV is by no means a certainty but it is certainly something you want to avoid. Neil McKellar-Stewart explains what it is, how it comes about and what you can do about it. read more »

HIV Seroconversion Study 2007 - 9

Scott Lockhart • 19 October 2009

The Seroconversion Study collects both quantitative and qualitative data from mainly homosexual men who have recently been diagnosed with HIV. Men are referred to the online questionaire through clinics and HIV organisations providing services to men who are newly diagnosed. Men completing the online questionaire volunteer for the more extended depth interview. read more »

Report from the Ninth ICAAP Conference in Bali

Report • John Trigg, NAPWHA APN+ Delegate • 3 September 2009

John Trigg attended the ICAAPInternational Congress on AIDS in Asia and the Pacific. IX Conference as NAPWHA Delegate. Here he reports on his experience of the Conference. read more »

Salvage Therapy

From Antiviral treatments • 12 August 2009

Some people with HIV with significant immune impairment, or people who have taken a wide range of antiviralA medication or substance which is active against one or more virusesA small infective organism which is incapable of reproducing outside a host cell.. May include anti-HIV drugs, but these are more accurately termed antiretroviralsA medication or other substance which is active against retroviruses such as HIV.. drugs over a period of many years may experience problems with their antiviral treatments because they are resistantHIV which has mutated and is less susceptible to the effects of one or more anti-HIV drugs is said to be resistant. to some classes of drugs. read more »

Treatment Breaks

From Antiviral treatments • 7 August 2009

At the turn of the century, combinations of three or more HIV antiviralA medication or substance which is active against one or more virusesA small infective organism which is incapable of reproducing outside a host cell.. May include anti-HIV drugs, but these are more accurately termed antiretroviralsA medication or other substance which is active against retroviruses such as HIV.. drugs were shown to be highly effective in treating HIV disease. At the time it was hoped that after long periods on these drugs it may be possible to ‘eradicate’ HIV from the body. In 2008 it is now known this is not possible with the current treatments. read more »

Adherance

From Antiviral treatments • 7 August 2009

Adherence (also referred to as compliance) means the extent to which you take the right dose of the drugs at the right time. Taking the right dose at the right time is important. Skipping doses can mean that the drug becomes ineffective against the virusA small infective organism which is incapable of reproducing outside a host cell. and allows resistanceHIV which has mutated and is less susceptible to the effects of one or more anti-HIV drugs is said to be resistantHIV which has mutated and is less susceptible to the effects of one or more anti-HIV drugs is said to be resistant.. to develop, see Resistanceread more »

Syndicate content
Text size: font smallerfont normalfont larger

Stay in touch

NAPWHA's email newsletters provide regular info about issues affecting people with HIV and the response to HIV in Australia. Click here to subscribe.

Subscribe to Positive Living

Our free quarterly newsmagazine, Positive Living provides authoritative, independent information about living with HIV and HIV treatments. Click here to subscribe.

RSS feeds

Our website has RSS feeds covering all topic areas — just go to the topic area you're interested in and click the RSS feed icon.

Twitter users can stay up-to-date with NAPWHA's work and be alerted to new content on the website by following @napwa.

Join us on Facebook NAPWHA Facebook.

Find out more at LinkedIn

Find out more about NAPWHA at LinkedInNAPWHA at LinkedIn.